Epilepsy Phenotypes of Vitamin B6-Dependent Diseases: An Updated Systematic Review
Children · 15.03.2023 · 10 (3) · 553
DOI: 10.3390/children10030553 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Children, online erschienen am 15.03.2023. Verfasst von Mario Mastrangelo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Child Neurology and Psychiatry Unit, Department of Human Neurosciences, Sapienza University of Rome, 00185 Rome, Italy. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Vitamin B6-dependent epilepsies include treatable diseases responding to pyridoxine or pyridoxal-5Iphosphate (ALDH7A1 deficiency, PNPO deficiency, PLP binding protein deficiency, hyperprolinemia type II and hypophosphatasia and glycosylphosphatidylinositol anchor synthesis defects). Patients and methods: We conducted a systematic review of published pediatric cases with a confirmed molecular genetic diagnosis of vitamin B6-dependent epilepsy according to PRISMA guidelines. Data on demographic features, seizure semiology, EEG patterns, neuroimaging, treatment, and developmental outcomes were collected.
Results
497 published patients fulfilled the inclusion criteria. Seizure onset manifested at 59.8 ± 291.6 days (67.8% of cases in the first month of life). Clonic, tonic-clonic, and myoclonic seizures accounted for two-thirds of the cases, while epileptic spasms were observed in 7.6%. Burst-suppression/suppression-burst represented the most frequently reported specific EEG pattern (14.4%), mainly in PLPB, ALDH7A1, and PNPO deficiency. Pyridoxine was administered to 312 patients (18.5% intravenously, 76.9% orally, 4.6% not specified), and 180 also received antiseizure medications. Pyridoxine dosage ranged between 1 and 55 mg/kg/die. Complete seizure freedom was achieved in 160 patients, while a significant seizure reduction occurred in 38. PLP, lysine-restricted diet, and arginine supplementation were used in a small proportion of patients with variable efficacy. Global developmental delay was established in 30.5% of a few patients in whom neurocognitive tests were performed.
Conclusions
Despite the wide variability, the most frequent hallmarks of the epilepsy phenotype in patients with vitamin B6-dependent seizures include generalized or focal motor seizure semiology and a burst suppression/suppression burst pattern in EEG.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Child Neurology and Psychiatry Unit, Department of Human Neurosciences, Sapienza University of Rome, 00185 Rome, Italy.
- Department of Neuroscience/Mental Health, Azienda Ospedaliero-Universitaria Policlinico Umberto I, 00161 Rome, Italy.
- Department of Neuropediatrics, University Children's Hospital Zurich and University of Zurich, 8032 Zurich, Switzerland.
ORCID-Profile: Mario Mastrangelo, Georgia Ramantani, Francesco Pisani
Zitieren
APA
Mastrangelo, M., Gasparri, V., Bernardi, K., Foglietta, S., Ramantani, G., & Pisani, F. (2023). Epilepsy Phenotypes of Vitamin B6-Dependent Diseases: An Updated Systematic Review. Children, 10(3), 553. https://doi.org/10.3390/children10030553
Vancouver
Mastrangelo M, Gasparri V, Bernardi K, Foglietta S, Ramantani G, Pisani F. Epilepsy Phenotypes of Vitamin B6-Dependent Diseases: An Updated Systematic Review. Children. 2023;10(3):553. doi:10.3390/children10030553
BibTeX
@article{Mastrangelo2023,
author = {Mastrangelo, Mario and Gasparri, Valentina and Bernardi, Katerina and Foglietta, Silvia and Ramantani, Georgia and Pisani, Francesco},
title = {Epilepsy Phenotypes of Vitamin B6-Dependent Diseases: An Updated Systematic Review},
journal = {Children},
year = {2023},
volume = {10},
number = {3},
pages = {553},
doi = {10.3390/children10030553}
}
EUVIMED